Today, in diverse medical and clinical fields, including cancer treatment, nanoscience has
evolved and evolved. Cancer and its forms, on the other hand, have been rumored and …

Liposomes were the first nanoscale drug to be approved for clinical use in 1995. Since then,
the technology has grown considerably, and pioneering recent work in liposome-based …

Liposomes have been extensively studied and are used in the treatment of several
diseases. Liposomes improve the therapeutic efficacy by enhancing drug absorption while …

Mesenchymal stromal cells (MSCs) are currently being investigated in numerous clinical
trials of tissue repair and various immunological disorders based on their ability to secrete …

Antimicrobial peptides (AMPs) have been described as excellent candidates to overcome
antibiotic resistance. Frequently, AMPs exhibit a wide therapeutic window, with low …

Abstract Background Mesenchymal stem cells (MSCs) are multipotent stem cells that can be
isolated and expanded from many tissues, and are being investigated for use in cell …

Abstract Background Antimicrobial peptides (AMPs) have gained wide interest as viable
alternatives to antibiotics owing to their potent antimicrobial effects and the low propensity of …

Viral carrier transport efficiency of gene delivery is high, depending on the type of vector.
However, viral delivery poses significant safety concerns such as inefficient/unpredictable …

In humans, six α (1, 3)-fucosyltransferases (α (1, 3)-FTs: FT3/FT4/FT5/FT6/FT7/FT9)
reportedly fucosylate terminal lactosaminyl glycans yielding Lewis-X (Le X; CD15) and/or …

Mesenchymal stem cells (MSCs) accumulate specifically in both primary tumors and
metastases following systemic administration. However, the poor payload capacity of MSCs …